Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q3 2018 · 10-Q
Revenue$858.00K$858.00K+83.7% vs Q3 2017 Net Income-$2.33M-$2.33MN/M vs Q3 2017 EPS Diluted-$27.63-$27.63N/M vs Q3 2017 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,647,000N/M Free Cash Flowderived-$2,697,000N/M Margins · derivedGross margin26.8%+31.1 pt vs Q3 2017
Operating margin-259.6%+670.4 pt vs Q3 2017
Net margin-271.6%+757.8 pt vs Q3 2017
ended Sep 30, 2018 · filed Nov 14, 2018 · 45 d after period end